Mitchell Jones - Feb 6, 2023 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role
Chief Medical Officer
Signature
/s/ Mitchell Jones
Stock symbol
PALI
Transactions as of
Feb 6, 2023
Transactions value $
-$939
Form type
4
Date filed
2/8/2024, 04:38 PM
Next filing
Sep 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PALI Common Stock, par value $0.01 Options Exercise $0 +4.56K +155.88% $0.00 7.48K Feb 6, 2024 Direct F1
transaction PALI Common Stock, par value $0.01 Options Exercise $0 +2.33K +31.18% $0.00 9.82K Feb 6, 2024 Direct F2
transaction PALI Common Stock, par value $0.01 Tax liability -$939 -2.15K -21.94% $0.44 7.66K Feb 6, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Restricted Stock Units Options Exercise -4.56K -9.09% 45.6K Feb 6, 2024 Common Stock 4.56K Direct F4, F5
transaction PALI Restricted Stock Units Options Exercise -2.33K -8.33% 25.7K Feb 6, 2024 Common Stock 2.33K Direct F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023.
F2 Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.
F3 Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units for each of the vested portions of the grant.
F4 Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
F5 This restricted stock unit was granted on September 5, 2023, and 4,558 restricted stock units subject to the award vested on February 6, 2024, and an additional 45,586 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.
F6 This restricted stock unit was granted on November 21, 2023, and 2,333 restricted stock units subject to the award vested on February 6, 2024, and an additional 25,667 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.